E-retail giant Catch Group has settled a lawsuit against Kogan for alleging violating its “catch” trade marks and the consumer law through sponsored links on Google driven by phrases using the word “catch”.
Actor Geoffrey Rush has been awarded at least $850,000 in damages after taking Nationwide News to court alleging it defamed him by tainting him as a sexual predator, with the judge calling the publisher’s conduct “improper and unjustified”.
Insurance Australia Limited is facing a class action alleging it engaged in misleading and deceptive conduct by pushing worthless add-on insurance onto individuals purchasing motor vehicles through authorised dealers.
The Australian Competition and Consumer Commission has brought criminal cartel charges against a money transfer business and five individuals for allegedly fixing the foreign exchange rate on millions of dollars transferred between Australia and Vietnam between 2011 and 2016.
A judge has slapped fines of $33,350 against the Construction, Forestry, Maritime, Mining and Energy union and a high-ranking official who pinned a project manager against a fence in a fight over a filthy portable toilet at a construction site in Adelaide.
Months after submitting its final report on the country’s class action regime, the Australian Law Reform Commission has been tasked with undertaking a “comprehensive” review of the effectiveness of the country’s corporate crime laws, including whether the criminal code should be altered to make senior executives liable for company misconduct.
A judge has refused a bid by Macquarie Bank and a group of former financial advisers to preside over a mediation of their spat over $2.6 million in wages, saying a judge can’t act as a mediator and he wouldn’t do it even if he could.
The Commonwealth Bank of Australia has offered $9.3 million since 2014 to customers that suffered loss when advisers in two of its financial planning units put their money into high-risk investments without their permission.
F. Hoffman La-Roche has reached a settlement in a patent lawsuit over Sandoz’s plan to market a biosimilar version of its patented biologic used to treat various cancers and rheumatoid arthritis.
Global pharmaceutical giant Lundbeck has launched a bid to escape a prior undertaking blocking it from appealing a court’s decision that allowed four generic drug makers to apply for licences to manufacture generic versions of popular antidepressant Lexapro.